CVE-2026-105457

MEDIUMCVSS 6.5/10EPSS 0.42%

Last modified

CVE-2026-105457 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: before 2.3.5-1132.. EPSS estimates a 0.42% chance of exploitation in the next 30 days.

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: before 2.3.5-1132.

Metrics

EPSS Probability
0.42%

36.6th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
HAVELSAN Inc.Liman MYS< 2.3.5-1132

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2026-105457?
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: before 2.3.5-1132.
How severe is CVE-2026-105457?
CVE-2026-105457 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.42% probability of exploitation in the next 30 days.
How do I fix CVE-2026-105457?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-105457?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST